In situ MUC1-specific CAR engineering of tumor-supportive macrophages stimulates tumoricidal immunity against pancreatic adenocarcinoma-Reference-Cited by-同舟云学术

In situ MUC1-specific CAR engineering of tumor-supportive macrophages stimulates tumoricidal immunity against pancreatic adenocarcinoma

Published:2023-04 Issue: Volume:49 Page:101805
ISSN:1748-0132
Container-title:Nano Today
language:en
Short-container-title:Nano Today

Author:

Liu Ying,Jing Weiqiang,Zhang Jing,Chen Chen,Gao Lin,Shi Chongdeng,Li Anning,Sun Peng,Zhang Rui,Yang Zhenmei,Tang Chunwei,Du Wei,Dong Yuanmin,Xu Jiawen,Zhao Kun,Jiang Xinyi^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Bioengineering,Biotechnology

Reference58 articles.

1. Pancreatic cancer

2. Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities

3. From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer

4. Regulation and modulation of antitumor immunity in pancreatic cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The complex role of macrophages in pancreatic cancer tumor microenvironment: a review on cancer progression and potential therapeutic targets;Discover Oncology;2024-08-26

2. A new era of cancer immunotherapy: combining revolutionary technologies for enhanced CAR-M therapy;Molecular Cancer;2024-06-01

3. Direct in vivo CAR T cell engineering;Trends in Pharmacological Sciences;2024-05

4. In Situ Reprogramming of Immune Cells Using Synthetic Nanomaterials;Advanced Materials;2024-01-22

5. NIR-II Light-driven genetically edited nanoparticles with inherent CRT-inducing capability for macrophage-mediated immunotherapy;Nano Today;2023-06